Fund Holdings — Versant Venture Management, LLC

Total Portfolio Value:
$77.30M
Total Bought:
$31.49M
Total Sold:
$8.95M
Net Transaction:
+$22.54M
Notable People:
Brian G. Atwood, Samuel D. Colella, Bradley J. Bolzon, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Robin L. Praeger, Robin L. Praeger, Thomas F. Woiwode, Samuel D. Colella, William J. Link, Kirk G. Nielsen, Bradley J. Bolzon, Thomas F. Woiwode, Thomas F. Woiwode, Bradley J. Bolzon, Robin L. Praeger, Kirk G. Nielsen, Thomas F. Woiwode, Versant Ventures Vi Gp-, Versant Venture, Versant Ventures Vii Gp-, Versant Vantage I Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Robin L. Praeger, Thomas F. Woiwode, Clare Ozawa, Clare Ozawa, Thomas F. Woiwode, Robin L. Praeger, Jerel Clayton Davis, Bradley J. Bolzon, Versant Ventures Vi Gp,, Jerel Clayton Davis, Jerel Clayton Davis, Clare Ozawa, Jerel Clayton Davis, Clare Ozawa, Alexander Volker Mayweg, Alexander Volker Mayweg, Versant Vantage Ii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Versant Voyageurs Ii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Ii Gp-, Versant Vantage Iii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Ix Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Iii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Vantage Iii Gp-Gp,, Versant Ventures Ix Gp-, Versant Voyageurs Iii Gp-, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CRISPR Therapeutics AG(CRSP)498,558498,5580$33.98M$26.93M34.84%-$7.05M
Contineum Therapeutics, Inc.(CTNM)0918,163+918,163$0$16.17M20.92%+$16.17M
Skye Bioscience, Inc.(SKYE)2,007,7022,007,704+2$31.40M$16.08M20.81%-$15.32M
Repare Therapeutics, Inc.2,646,6572,646,6570$12.47M$8.73M11.30%-$3.73M
Adverum Biotechnologies, Inc.506,822506,821-1$7.17M$3.48M4.50%-$3.69M
Passage Bio, Inc.(PASG)4,959,7694,026,417-933,352$6.70M$3.20M4.14%-$3.50M
Gritstone Oncology, Inc.3,561,1503,561,1500$9.15M$2.20M2.85%-$6.95M
Aligos Therapeutics, Inc.2,320,3811,457,937-862,444$2.27M$510.3K0.66%-$1.76M
Page 1 of 1
Versant Venture Management, LLC — 13F Holdings — Q2 2024 | TickerTrail